ACCENDRA HEALTH INC/VA/
Close on Oct 19, 2026
- Market cap
- $16.89M
- P/E (TTM)
- –
- Dividend yield
- –
About Accendra Health
Wholesale-Medical, Dental & Hospital Equipment & Supplies, SIC 5047
Accendra Health, Inc. provides medical supplies, technology, and home healthcare equipment across the United States. Its offerings focus on home respiratory therapy, obstructive sleep apnea treatment, diabetes care, wound care, and ostomy supplies. The company also delivers clinical support and patient management services designed to facilitate medical treatment outside acute care facilities. It operates primarily under brands such as Apria and Byram Healthcare, distributing products directly to individual patients as well as home health agencies. Reimbursement and payment arrangements involve commercial health insurers, managed care plans, state Medicaid programs, federal Medicare coverage, and direct out-of-pocket patient payments.
The company conducts nationwide operations across the United States and maintains medical gas facilities along with distribution centers across multiple states. At the end of 2025, the organization employed more than 6,500 full-time and part-time workers. Its corporate headquarters are located in Richmond, Virginia.
Summary of the business section of Accendra Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- ACCENDRA HEALTH INC/VA/
- Founded
- 1882
- Headquarters
- Glen Allen, VA
- Address
- 4435 Waterfront Drive, Suite 300
- Phone
- (804) 277-4304
- Website
- owens-minor.com
- Employees
- 6,500, Dec 31, 2025
- Industry
- Wholesale-Medical, Dental & Hospital Equipment & Supplies
- Incorporated in
- Virginia
- Fiscal year ends
- December 31
- Auditor
- KPMG, LLP, Richmond, VA
Stock & identifiers
- Ticker
- ACH
- Exchange
- NYSE
- Shares outstanding
- 77M, Jun 30, 2026
- Public float
- $677.54M, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 3-for-2, Apr 1, 2010; 3-for-2, Jun 9, 1994; 3-for-2, Mar 23, 1993; 3-for-2, Jul 17, 1991; 3-for-2, Jun 1, 1988; 3-for-2, Sep 3, 1985; 2-for-1, Nov 1, 1982
- SEC CIK
- 75252
- CUSIP
- 690732102
- ISIN
- US6907321029
- LEI
- 549300LMT5KQQXCEZ733
- EIN
- 54-1701843
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Edward A. Pesicka | President & CEO, Director | 1,072,785 |
| Jonathan A. Leon | EVP & CFO | 286,268 |
| Heath H. Galloway | EVP,General Counsel & CorpSecy | 166,306 |
| Perry A. Bernocchi | EVP, Chief Operating Officer | 313,913 |
| Andrew G. Long | EVP, CEO P&HS | 448,425 |
| Jennifer A. Stone | EVP, CHRO | 110,327 |
| Michael Wayne Lowry | SVP, Corporate Controller | 121,921 |
| Stephen W. Klemash | Director | 90,242 |
| Gwendolyn M. Bingham | Director | 22,184 |
| Kenneth Gardner-Smith | Director | 86,113 |
| Teresa L. Kline | Director | 85,316 |
| Mark A. Beck | Director | 71,259 |
| Carissa Rollins | Director | 53,902 |
| Rita Johnson-Mills | Director | 54,125 |
| Robert J. Henkel | Director | 77,412 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Edward A. Pesicka | $11.16M | -$1.11M | $3.05M | $10 | $111 |
| FY2024 Edward A. Pesicka | $10.74M | $6.63M | $3.01M | $48 | $105 |
| FY2023 Edward A. Pesicka | $8.39M | $2.43M | $3.27M | $71 | $99 |
| FY2022 Edward A. Pesicka | $6.25M | -$20.49M | $2.78M | $72 | $94 |
| FY2021 Edward A. Pesicka | $7.68M | $42.84M | $3.38M | $161 | $121 |
| FY2020 Edward A. Pesicka | $7.63M | $56.61M | $2.28M | $524 | $126 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“At the end of 2025, following the sale of our Products & Healthcare Services segment (the “P&HS Sale”), we employed over 6,500 full-time and part-time teammates.”
Corporate history
Events identified from SEC filings